Prescription drug · ANDA

Meropenem NDC 68001-324

Meropenem 1 g/30mL · Injection, Powder, For solution · Intravenous · BluePoint Laboratories

NDC codes

FDA NDC Directory
Product NDC (as listed)68001-324Labeler and product segments. Claims need a package NDC.
Product NDC at billing width68001-0324Add the package segment from the table below.

Product information

Brand name (proprietary)
Meropenem
Generic name (nonproprietary)
meropenem
Active ingredients
Meropenem — 1 g/30mL
Dosage form
Injection, Powder, For solution
Route
Intravenous
Labeler
BluePoint LaboratoriesNDC labeler code 68001
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 205883
Marketing start
Listing expires
Other FDA classes
Carbapenems (Chemical structure)
Identifiers
Product ID 68001-324_45bbbbfc-a4d7-c7ed-e063-6294a90aca41SPL ID 45bbbbfc-a4d7-c7ed-e063-6294a90aca41SPL set ID ca5f501c-6520-4d09-aae2-4f5db74d468fRxCUI 1722934, 1722939UNII FV9J3JU8B1UPC 0368001323291, 0368001324588
Pharmacologic class
Penem Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Meropenem for injection (I.V.) is a penem antibacterial indicated for the treatment of: Complicated skin and skin structure infections (adult patients and pediatric patients 3 months of age and older only). (1.1) Complicated intra-abdominal infections (adult and pediatric patients). (1.2) Bacterial meningitis (pediatric patients 3 months of age and older only). (1.3) To reduce the development of drug-resistant bacteria and maintain the effectiveness of meropenem for injection (I.V.) and other antibacterial drugs, meropenem for injection (I.V.) should only be used to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. 1.1 Complicated Skin an…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68001-324

What is NDC 68001-324?
68001-324 is the product NDC for Meropenem, Meropenem 1 g/30mL injection, powder, for solution, listed with the FDA by BluePoint Laboratories.
What drug is associated with this NDC?
Meropenem.
What is the active ingredient?
Meropenem.
Who is the labeler?
BluePoint Laboratories, NDC labeler code 68001. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Meropenem?
46 other product NDCs are listed under this name. See all Meropenem NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Meropenem NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
MeropenemMeropenem 500 mg/10mLInjection, Powder, For solutionIntravenousHikma Pharmaceuticals USA Inc.0143-948500143-9485-10
MeropenemMeropenem 1 g/20mLInjection, Powder, For solutionIntravenousHikma Pharmaceuticals USA Inc.0143-948600143-9486-10
MeropenemMeropenem 500 mg/20mLInjection, Powder, For solutionIntravenousSagent Pharmaceuticals25021-16025021-0160-20
MeropenemMeropenem 1 g/30mLInjection, Powder, For solutionIntravenousSagent Pharmaceuticals25021-16125021-0161-30
MeropenemMeropenem 1 g/20mLInjectionIntravenousCivica, Inc.72572-41072572-0410-10
MeropenemMeropenem 500 mg/20mLInjectionIntravenousCivica, Inc.72572-41272572-0412-10
MeropenemMeropenem anhydrous 2 g/1InjectionIntravenousMylan Institutional LLC72078-08172078-0081-06
MeropenemMeropenem anhydrous 2 g/1InjectionIntravenousBROOKS STERISCIENCE LIMITED81962-00281962-0002-08
MeropenemMeropenem 500 mg/20mLInjectionIntravenousQilu Antibiotics Pharmaceutical Co., Ltd.51810-50251810-0502-02
MeropenemMeropenem 1 g/30mLInjectionIntravenousQilu Antibiotics Pharmaceutical Co., Ltd.51810-50351810-0503-02

All 47 Meropenem NDCs

Other NDCs under ANDA 205883

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205883
ProductStrengthForm · routeLabelerProduct NDC
MeropenemMeropenem 500 mg/20mLInjection, Powder, For solutionIntravenousBluePoint Laboratories68001-323
MeropenemMeropenem 500 mg/20mLInjection, Powder, For solutionIntravenousAmneal Pharmaceuticals LLC70121-1454
MeropenemMeropenem 1 g/30mLInjection, Powder, For solutionIntravenousAmneal Pharmaceuticals LLC70121-1453

Med-Code uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in
Meropenem NDC 68001-324 | National Drug Code | Med-Code